Grimes & Company, Inc. Eli Lilly & CO Transaction History

Grimes & Company, Inc.

$3.66 Billion
Q3 2024

A detailed history of Grimes & Company, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Grimes & Company, Inc. holds 4,073 shares of LLY stock, worth $3.21 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

4,073

Previous 3,747 8.7%

Holding current value

$3.21 Million

Previous $3.39 Million 6.37%

% of portfolio

0.1%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$772.14 - $960.02 $251,717 - $312,966	326 Added 8.7%	4,073 $3.61 Million
Q2 2024 Jul 22, 2024	SELL	$724.87 - $909.04 $61,613 - $77,268	-85 Reduced 2.22%	3,747 $3.39 Million
Q1 2024 Apr 17, 2024	SELL	$592.2 - $792.28 $620,033 - $829,517	-1,047 Reduced 21.46%	3,832 $2.98 Million
Q4 2023 Jan 24, 2024	BUY	$525.19 - $619.13 $499,980 - $589,411	952 Added 24.24%	4,879 $2.84 Million
Q3 2023 Oct 19, 2023	BUY	$434.7 - $599.3 $8,694 - $11,986	20 Added 0.51%	3,927 $2.11 Million
Q2 2023 Jul 19, 2023	SELL	$350.74 - $468.98 $4,559 - $6,096	-13 Reduced 0.33%	3,907 $1.83 Million
Q1 2023 Apr 20, 2023	BUY	$310.63 - $364.82 $40,692 - $47,791	131 Added 3.46%	3,920 $1.35 Million
Q4 2022 Jan 25, 2023	BUY	$321.55 - $374.67 $3,215 - $3,746	10 Added 0.26%	3,789 $0
Q3 2022 Oct 28, 2022	BUY	$296.48 - $337.87 $5,336 - $6,081	18 Added 0.48%	3,779 $1.22 Million
Q2 2022 Jul 22, 2022	SELL	$278.73 - $327.27 $12,542 - $14,727	-45 Reduced 1.18%	3,761 $1.22 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $17,836 - $22,166	-76 Reduced 1.96%	3,806 $1.09 Million
Q3 2021 Nov 08, 2021	BUY	$221.6 - $272.71 $11,966 - $14,726	54 Added 1.41%	3,882 $897,000
Q2 2021 Aug 04, 2021	BUY	$180.55 - $233.54 $2,527 - $3,269	14 Added 0.37%	3,828 $878,000
Q1 2021 May 12, 2021	SELL	$164.32 - $212.72 $130,470 - $168,899	-794 Reduced 17.23%	3,814 $713,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $2,339 - $2,706	-16 Reduced 0.35%	4,608 $683,000
Q1 2020 May 05, 2020	BUY	$119.05 - $147.35 $30,119 - $37,279	253 Added 5.79%	4,624 $641,000
Q4 2019 Feb 05, 2020	BUY	$106.92 - $132.43 $3,100 - $3,840	29 Added 0.67%	4,371 $574,000
Q2 2019 Jul 30, 2019	SELL	$110.79 - $129.32 $6,315 - $7,371	-57 Reduced 1.3%	4,342 $481,000
Q1 2019 May 02, 2019	BUY	$111.31 - $131.02 $19,701 - $23,190	177 Added 4.19%	4,399 $571,000
Q4 2018 Feb 01, 2019	SELL	$105.9 - $118.64 $13,237 - $14,830	-125 Reduced 2.88%	4,222 $489,000
Q3 2018 Nov 09, 2018	BUY	$85.86 - $107.31 $4,293 - $5,365	50 Added 1.16%	4,347 $466,000
Q2 2018 Aug 10, 2018	BUY	$75.7 - $86.88 $60,560 - $69,504	800 Added 22.88%	4,297 $367,000
Q1 2018 May 07, 2018	BUY	$74.21 - $87.6 $259,512 - $306,337	3,497 New	3,497 $270,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Grimes & Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Grimes & Company, Inc. with notifications on news.

Account

Grimes & Company, Inc. Eli Lilly & CO Transaction History